NASDAQ:FEMY Femasys (FEMY) Stock Price, News & Analysis $2.53 -0.06 (-2.32%) As of 09/21/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Femasys Stock (NASDAQ:FEMY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Femasys alerts:Sign Up Key Stats Today's Range$2.53▼$2.6350-Day Range$2.16▼$3.9152-Week Range$2.02▼$22.20Volume32,282 shsAverage Volume124,856 shsMarket Capitalization$21.20 millionP/E RatioN/ADividend YieldN/APrice Target$50.00Consensus RatingModerate Buy Company Overview Femasys Inc. is a women’s health company focused on developing and commercializing minimally invasive technologies for reproductive health and fertility care. The company’s products are designed to provide non-surgical or less invasive alternatives for contraception, diagnostic procedures and treatments involving the female reproductive system. Femasys’ lead product candidate is FemBloc, an investigational, non-surgical permanent birth-control system intended to prevent pregnancy by blocking the fallopian tubes. The company is also developing FemCath, a transcervical catheter designed to facilitate access to the fallopian tubes for diagnostic and therapeutic procedures. Its product portfolio has also included FemVue, a system used in certain fertility-related procedures to evaluate fallopian-tube patency. Founded in 2004 and based in Atlanta, Georgia, Femasys primarily operates in the United States and is advancing its technologies through clinical development, regulatory activities and commercialization efforts. The company is led by founder and Chief Executive Officer Kathy Lee-Sepsick.AI Generated. May Contain Errors. Read More Femasys Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreFEMY MarketRank™: Femasys scored higher than 67% of companies evaluated by MarketBeat, and ranked 241st out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingModerate Buy Consensus RatingFemasys has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialFemasys has a consensus price target of $50.00, representing about 1,876.3% upside from its current price of $2.53.Amount of Analyst CoverageFemasys has only been the subject of 3 research reports in the past 90 days.Read more about Femasys' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Femasys is -0.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Femasys is -0.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFemasys has a P/B Ratio of 1.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Femasys' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.68% of the float of Femasys has been sold short.Short Interest Ratio / Days to CoverFemasys has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Femasys has recently increased by 36.34%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFemasys does not currently pay a dividend.Dividend GrowthFemasys does not have a long track record of dividend growth. News and Social Media2.5 / 5News Sentiment0.07 News SentimentFemasys has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Femasys this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for FEMY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Femasys to their MarketBeat watchlist in the last 30 days. Company Ownership4.6 / 5Insider TradingAcquiring Shares Cluster Insider Buying4 insiders have purchased shares of Femasys in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $124,000.00 in company stock, which represents 0.5849% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Femasys insiders have bought more of their company's stock than they have sold. Specifically, they have bought $124,000.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders7.75% of the stock of Femasys is held by insiders.Percentage Held by Institutions65.27% of the stock of Femasys is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Femasys' insider trading history. Receive FEMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Femasys and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FEMY Stock News HeadlinesFemasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s CareSeptember 15, 2026 | finance.yahoo.comFemasys Expands Fertility Portfolio Adoption Through Minnesota Women's CareSeptember 15, 2026 | rttnews.comA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Across the country, protests, lawsuits, and moratoria are targeting AI infrastructure projects. Whitney Tilson, former hedge fund manager and editor of Stansberry's Investment Advisory, says November 4 could bring this conflict to a head, with major implications for investors' portfolios. | Stansberry Research (Ad)Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women's CareSeptember 15, 2026 | globenewswire.comReviewing Solventum (NYSE:SOLV) and Femasys (NASDAQ:FEMY)September 12, 2026 | americanbankingnews.comFemasys Partners With CapexMD To Expand Access To FemaSeed Fertility PortfolioSeptember 9, 2026 | rttnews.comFemasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility PortfolioSeptember 9, 2026 | globenewswire.comFemasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care LocationsAugust 26, 2026 | globenewswire.comSee More Headlines FEMY Stock Analysis - Frequently Asked Questions How have FEMY shares performed this year? Femasys' stock was trading at $11.5240 on January 1st, 2026. Since then, FEMY shares have decreased by 78.0% and is now trading at $2.53. How were Femasys' earnings last quarter? Femasys Inc. (NASDAQ:FEMY) released its earnings results on Friday, August, 14th. The company reported ($1.33) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.31) by $0.02. The firm had revenue of $0.33 million for the quarter, compared to analyst estimates of $0.73 million. Femasys had a negative net margin of 534.36% and a negative trailing twelve-month return on equity of 225.97%. When did Femasys' stock split? Shares of Femasys reverse split before market open on Monday, June 8th 2026.The 1-20 reverse split was announced on Thursday, June 4th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 5th 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Femasys IPO? Femasys (FEMY) raised $34 million in an initial public offering (IPO) on Wednesday, June 16th 2021. The company issued 2,650,000 shares at $12.00-$14.00 per share. Chardan and JonesTrading acted as the underwriters for the IPO. How do I buy shares of Femasys? Shares of FEMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Femasys own? Based on aggregate information from My MarketBeat watchlists, some other companies that Femasys investors own include Sangamo Therapeutics (SGMO), Aurora Cannabis (ACB), Canoo (GOEV), FuelCell Energy (FCEL), Agenus (AGEN), Geron (GERN) and Eos Energy Enterprises (EOSE). Company Calendar Last Earnings8/14/2026Today9/22/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 FEMY's financial health is in the Red zone, according to TradeSmith. FEMY has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:FEMY CIK1339005 Webwww.femasys.com Phone770-500-3910FaxN/AEmployees54Year Founded2004Price Target and Rating Average Price Target for Femasys$50.00 High Price Target$130.00 Low Price Target$10.00 Potential Upside/Downside+1,876.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($3.53) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$18.63 million Net Margins-534.36% Pretax Margin-511.61% Return on Equity-225.97% Return on Assets-74.68% Debt Debt-to-Equity Ratio0.89 Current Ratio2.14 Quick Ratio0.55 Sales & Book Value Annual Sales$2.29 million Price / Sales9.26 Cash FlowN/A Price / Cash FlowN/A Book Value$2.01 per share Price / Book1.26Miscellaneous Outstanding Shares8,380,000Free Float7,726,000Market Cap$21.20 million OptionableNot Optionable Beta-2.07 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:FEMY) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our PartnersThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored10% yields… from a gold security?Most stocks yield under 2%. Even gold stocks average less than 1%. One gold security, backed by one of the wor...Golden Portfolio | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
